Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6

Long noncoding RNAs (lncRNAs) have an effect on the occurrence and progression of a considerable number of diseases, especially cancer. Existing research has suggested that MAGI2 antisense RNA 3 (MAGI2-AS3) takes on a critical significance in the development of hepatocellular carcinoma and lung canc...

Full description

Bibliographic Details
Main Authors: Jiantao Wang, Chuan Yang, Huan Cao, Jianwang Yang, Wenxia Meng, Miaomiao Yu, Lei Yu, Baoshan Wang
Format: Article
Language:English
Published: SAGE Publishing 2023-02-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897231154574
_version_ 1811163067631796224
author Jiantao Wang
Chuan Yang
Huan Cao
Jianwang Yang
Wenxia Meng
Miaomiao Yu
Lei Yu
Baoshan Wang
author_facet Jiantao Wang
Chuan Yang
Huan Cao
Jianwang Yang
Wenxia Meng
Miaomiao Yu
Lei Yu
Baoshan Wang
author_sort Jiantao Wang
collection DOAJ
description Long noncoding RNAs (lncRNAs) have an effect on the occurrence and progression of a considerable number of diseases, especially cancer. Existing research has suggested that MAGI2 antisense RNA 3 (MAGI2-AS3) takes on a critical significance in the development of hepatocellular carcinoma and lung cancer. However, the functions of MAGI2-AS3 in laryngeal squamous cell carcinoma (LSCC) remain unclear. In this study, MAGI2-AS3 expression level in LSCC tissue and cell lines was detected, and the effect of MAGI2-AS3 overexpressed on LSCC phenotypes and the possible influence mechanisms were examined. MAGI2-AS3 was downregulated in the tissues of LSCC patients versus non-tumor tissues, and it was correlated with advanced TNM (tumor, node, metastasis) stage and lymph node metastases, as indicated by the results of this study. MAGI2-AS3 inhibited the proliferation, migration, and invasion of LSCC cells in vitro and in vivo . Furthermore, the hypermethylation level of the MAGI2-AS3 promoter region was indicated by bisulfite genomic sequencing and methylation-specific polymerase chain reaction, such that MAGI2-AS3 expression was downregulated. Besides, MAGI2-AS3 promoter hypermethylation was regulated by DNA methyltransferase 1 (DNMT1), and MAGI2-AS3 expression was reversed by 5-Aza-2′-deoxycytidine (5-Aza). Moreover, the result of the RNA pull-down experiment suggested that 38 proteins were enriched in the MAGI2-AS3 group versus the control group in TU177 cells. To be specific, SPT6 (ie, a conserved protein) was enriched by fold change >10. SPT6 knockdown reduced the antitumor effect of MAGI2-AS3 in TU177 and AMC-HN-8 cells. Meanwhile, SPT6 overexpression inhibited the proliferation, metastasis, and invasion of TU177 and AMC-HN-8 cells. As revealed by the above findings, DNMT1-regulated MAGI2-AS3 promoter hypermethylation led to downregulated MAGI2-AS3 expression, such that the presence and progression of LSCC were inhibited in an SPT6 binding-dependent manner.
first_indexed 2024-04-10T06:39:12Z
format Article
id doaj.art-0a505466c54846e898822e56f84fd5a8
institution Directory Open Access Journal
issn 1555-3892
language English
last_indexed 2024-04-10T06:39:12Z
publishDate 2023-02-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-0a505466c54846e898822e56f84fd5a82023-02-28T15:33:36ZengSAGE PublishingCell Transplantation1555-38922023-02-013210.1177/09636897231154574Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6Jiantao Wang0Chuan Yang1Huan Cao2Jianwang Yang3Wenxia Meng4Miaomiao Yu5Lei Yu6Baoshan Wang7Department of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaLong noncoding RNAs (lncRNAs) have an effect on the occurrence and progression of a considerable number of diseases, especially cancer. Existing research has suggested that MAGI2 antisense RNA 3 (MAGI2-AS3) takes on a critical significance in the development of hepatocellular carcinoma and lung cancer. However, the functions of MAGI2-AS3 in laryngeal squamous cell carcinoma (LSCC) remain unclear. In this study, MAGI2-AS3 expression level in LSCC tissue and cell lines was detected, and the effect of MAGI2-AS3 overexpressed on LSCC phenotypes and the possible influence mechanisms were examined. MAGI2-AS3 was downregulated in the tissues of LSCC patients versus non-tumor tissues, and it was correlated with advanced TNM (tumor, node, metastasis) stage and lymph node metastases, as indicated by the results of this study. MAGI2-AS3 inhibited the proliferation, migration, and invasion of LSCC cells in vitro and in vivo . Furthermore, the hypermethylation level of the MAGI2-AS3 promoter region was indicated by bisulfite genomic sequencing and methylation-specific polymerase chain reaction, such that MAGI2-AS3 expression was downregulated. Besides, MAGI2-AS3 promoter hypermethylation was regulated by DNA methyltransferase 1 (DNMT1), and MAGI2-AS3 expression was reversed by 5-Aza-2′-deoxycytidine (5-Aza). Moreover, the result of the RNA pull-down experiment suggested that 38 proteins were enriched in the MAGI2-AS3 group versus the control group in TU177 cells. To be specific, SPT6 (ie, a conserved protein) was enriched by fold change >10. SPT6 knockdown reduced the antitumor effect of MAGI2-AS3 in TU177 and AMC-HN-8 cells. Meanwhile, SPT6 overexpression inhibited the proliferation, metastasis, and invasion of TU177 and AMC-HN-8 cells. As revealed by the above findings, DNMT1-regulated MAGI2-AS3 promoter hypermethylation led to downregulated MAGI2-AS3 expression, such that the presence and progression of LSCC were inhibited in an SPT6 binding-dependent manner.https://doi.org/10.1177/09636897231154574
spellingShingle Jiantao Wang
Chuan Yang
Huan Cao
Jianwang Yang
Wenxia Meng
Miaomiao Yu
Lei Yu
Baoshan Wang
Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
Cell Transplantation
title Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
title_full Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
title_fullStr Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
title_full_unstemmed Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
title_short Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
title_sort hypermethylation mediated lncrna magi2 as3 downregulation facilitates malignant progression of laryngeal squamous cell carcinoma via interacting with spt6
url https://doi.org/10.1177/09636897231154574
work_keys_str_mv AT jiantaowang hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT chuanyang hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT huancao hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT jianwangyang hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT wenxiameng hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT miaomiaoyu hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT leiyu hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6
AT baoshanwang hypermethylationmediatedlncrnamagi2as3downregulationfacilitatesmalignantprogressionoflaryngealsquamouscellcarcinomaviainteractingwithspt6